Jaguar Health (JAGX) Net Income towards Common Stockholders Growth (3y) (2017 - 2026)
Jaguar Health (JAGX) Net Income towards Common Stockholders Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,774.59 Bn | 1,774.53 Bn | - | - |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 3 | BeOne Medicines | 473.53 Bn | 468.74 Bn | 1.35 Bn | 38.43% |
| 4 | Vertex Pharmaceuticals | 123.91 Bn | 116.66 Bn | 2.59 Bn | 13.80% |
| 5 | Regeneron Pharmaceuticals | 71.79 Bn | 63.04 Bn | 3.31 Bn | -3.84% |
| 6 | Belite Bio | 62.15 Bn | 62.15 Bn | - | - |
| 7 | Argenx Se | 54.75 Bn | 49.57 Bn | 1.41 Bn | 71.02% |
| 8 | Alnylam Pharmaceuticals | 38.10 Bn | 35.10 Bn | 959.66 Mn | 47.10% |
| 9 | Revolution Medicines | 36.11 Bn | 36.11 Bn | - | - |
| 10 | Jaguar Health | 509,443.80 | -9.55 Mn | 19.11 Mn | 16.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.85% |
| Dec 31, 2025 | -45.17% |
| Sep 30, 2025 | 8.32% |
| Jun 30, 2025 | -4.08% |
| Mar 31, 2025 | 16.52% |
| Dec 31, 2024 | 10.58% |
| Sep 30, 2024 | 6.33% |
| Jun 30, 2024 | 12.32% |
| Mar 31, 2024 | 8.41% |
| Dec 31, 2023 | 6.90% |
| Sep 30, 2023 | 2.03% |
| Jun 30, 2023 | -4.66% |
| Mar 31, 2023 | -13.18% |
| Dec 31, 2022 | 1.85% |
| Sep 30, 2022 | -2.33% |
| Jun 30, 2022 | 17.56% |
| Mar 31, 2022 | -29.38% |
| Dec 31, 2021 | -7.08% |
| Sep 30, 2021 | -25.70% |
| Jun 30, 2021 | -17.63% |